LeMaitre Gross Profit from 2010 to 2024

LMAT Stock

USD 107.09 0.88 0.82%

LeMaitre Vascular Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit LeMaitre Vascular makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2004-03-31

Previous Quarter

37 M

Current Value

37.2 M

Quarterly Volatility

8.2 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check LeMaitre Vascular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LeMaitre Vascular's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Total Revenue of 203.2 M or Gross Profit of 133.4 M, as well as many indicators such as Price To Sales Ratio of 6.84, Dividend Yield of 0.0125 or PTB Ratio of 4.64. LeMaitre financial statements analysis is a perfect complement when working with LeMaitre Vascular Valuation or Volatility modules.

Check out the analysis of LeMaitre Vascular Correlation against competitors.

For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.

Latest LeMaitre Vascular's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of LeMaitre Vascular over the last few years. Gross profit is a required income statement account that reflects total revenue of LeMaitre Vascular minus its cost of goods sold. It is profit before LeMaitre Vascular operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. LeMaitre Vascular's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LeMaitre Vascular's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 104.9 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

LeMaitre Gross Profit Regression Statistics

	Arithmetic Mean	71,686,363
	Geometric Mean	60,993,937
	Coefficient Of Variation	48.27
	Mean Deviation	27,111,188
	Median	70,697,000
	Standard Deviation	34,600,147
	Sample Variance	1197.2T
	Range	125.7M
	R-Value	0.98
	Mean Square Error	58.2T
	R-Squared	0.95
	Slope	7,560,247
	Total Sum of Squares	16760.4T

LeMaitre Gross Profit History

	2024	133.4 M
	2023	127 M
	2022	104.9 M
	2021	101.4 M
	2020	84.6 M
	2019	79.9 M
	2018	73.9 M

Other Fundumenentals of LeMaitre Vascular

Gross Profit Margin

LeMaitre Vascular Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Total Current Assets	Short Term Debt	Current Deferred Revenue	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Treasury Stock	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Capital Stock	Short Long Term Debt
Total Assets		0.99	0.5	0.84	0.97	0.53	0.32	0.99	0.96	0.9	0.83	0.98	0.9	-0.8	0.92	0.74	0.89	0.99	0.86	-0.74	0.93	0.83	0.93	-0.63
Total Stockholder Equity	0.99		0.41	0.77	0.99	0.48	0.24	0.98	0.96	0.87	0.82	0.96	0.93	-0.8	0.87	0.74	0.89	0.98	0.87	-0.73	0.93	0.86	0.95	-0.64
Net Debt	0.5	0.41		0.79	0.31	0.43	0.77	0.51	0.44	0.57	0.39	0.63	0.24	-0.25	0.74	0.16	0.43	0.47	0.4	-0.5	0.57	0.27	0.44	-0.11
Total Liab	0.84	0.77	0.79		0.71	0.7	0.61	0.82	0.8	0.84	0.75	0.9	0.54	-0.7	0.93	0.63	0.69	0.79	0.63	-0.6	0.77	0.5	0.68	-0.4
Total Current Assets	0.97	0.99	0.31	0.71		0.43	0.13	0.97	0.97	0.85	0.79	0.91	0.95	-0.77	0.8	0.72	0.85	0.98	0.84	-0.7	0.89	0.86	0.94	-0.71
Short Term Debt	0.53	0.48	0.43	0.7	0.43		0.35	0.45	0.43	0.41	0.71	0.6	0.21	-0.63	0.67	0.66	0.42	0.42	0.53	-0.27	0.57	0.39	0.33	-0.05
Current Deferred Revenue	0.32	0.24	0.77	0.61	0.13	0.35		0.31	0.23	0.46	0.36	0.47	0.01	-0.34	0.59	0.31	0.49	0.26	0.26	-0.32	0.32	0.0	0.16	0.2
Retained Earnings	0.99	0.98	0.51	0.82	0.97	0.45	0.31		0.96	0.92	0.81	0.97	0.91	-0.75	0.89	0.69	0.88	1.0	0.85	-0.77	0.93	0.83	0.93	-0.64
Accounts Payable	0.96	0.96	0.44	0.8	0.97	0.43	0.23	0.96		0.88	0.78	0.92	0.89	-0.77	0.82	0.7	0.79	0.97	0.77	-0.67	0.86	0.79	0.9	-0.72
Long Term Debt	0.9	0.87	0.57	0.84	0.85	0.41	0.46	0.92	0.88		0.76	0.9	0.76	-0.71	0.86	0.64	0.83	0.9	0.75	-0.76	0.83	0.68	0.78	-0.49
Net Receivables	0.83	0.82	0.39	0.75	0.79	0.71	0.36	0.81	0.78	0.76		0.84	0.66	-0.88	0.79	0.91	0.78	0.79	0.9	-0.52	0.83	0.74	0.62	-0.2
Good Will	0.98	0.96	0.63	0.9	0.91	0.6	0.47	0.97	0.92	0.9	0.84		0.81	-0.8	0.97	0.73	0.89	0.95	0.84	-0.74	0.94	0.76	0.89	-0.52
Short Term Investments	0.9	0.93	0.24	0.54	0.95	0.21	0.01	0.91	0.89	0.76	0.66	0.81		-0.6	0.69	0.54	0.81	0.93	0.82	-0.71	0.86	0.9	0.94	-0.72
Treasury Stock	-0.8	-0.8	-0.25	-0.7	-0.77	-0.63	-0.34	-0.75	-0.77	-0.71	-0.88	-0.8	-0.6		-0.74	-0.97	-0.77	-0.73	-0.7	0.36	-0.67	-0.55	-0.6	0.25
Intangible Assets	0.92	0.87	0.74	0.93	0.8	0.67	0.59	0.89	0.82	0.86	0.79	0.97	0.69	-0.74		0.67	0.85	0.86	0.79	-0.72	0.91	0.68	0.82	-0.39
Common Stock	0.74	0.74	0.16	0.63	0.72	0.66	0.31	0.69	0.7	0.64	0.91	0.73	0.54	-0.97	0.67		0.73	0.67	0.71	-0.33	0.63	0.54	0.5	-0.16
Property Plant Equipment	0.89	0.89	0.43	0.69	0.85	0.42	0.49	0.88	0.79	0.83	0.78	0.89	0.81	-0.77	0.85	0.73		0.86	0.82	-0.67	0.83	0.72	0.81	-0.41
Net Tangible Assets	0.99	0.98	0.47	0.79	0.98	0.42	0.26	1.0	0.97	0.9	0.79	0.95	0.93	-0.73	0.86	0.67	0.86		0.85	-0.77	0.92	0.84	0.94	-0.67
Capital Surpluse	0.86	0.87	0.4	0.63	0.84	0.53	0.26	0.85	0.77	0.75	0.9	0.84	0.82	-0.7	0.79	0.71	0.82	0.85		-0.7	0.94	0.93	0.78	-0.31
Deferred Long Term Liab	-0.74	-0.73	-0.5	-0.6	-0.7	-0.27	-0.32	-0.77	-0.67	-0.76	-0.52	-0.74	-0.71	0.36	-0.72	-0.33	-0.67	-0.77	-0.7		-0.78	-0.69	-0.75	0.44
Net Invested Capital	0.93	0.93	0.57	0.77	0.89	0.57	0.32	0.93	0.86	0.83	0.83	0.94	0.86	-0.67	0.91	0.63	0.83	0.92	0.94	-0.78		0.92	0.91	-0.48
Net Working Capital	0.83	0.86	0.27	0.5	0.86	0.39	0.0	0.83	0.79	0.68	0.74	0.76	0.9	-0.55	0.68	0.54	0.72	0.84	0.93	-0.69	0.92		0.86	-0.52
Capital Stock	0.93	0.95	0.44	0.68	0.94	0.33	0.16	0.93	0.9	0.78	0.62	0.89	0.94	-0.6	0.82	0.5	0.81	0.94	0.78	-0.75	0.91	0.86		-0.75
Short Long Term Debt	-0.63	-0.64	-0.11	-0.4	-0.71	-0.05	0.2	-0.64	-0.72	-0.49	-0.2	-0.52	-0.72	0.25	-0.39	-0.16	-0.41	-0.67	-0.31	0.44	-0.48	-0.52	-0.75

Click cells to compare fundamentals

About LeMaitre Vascular Financial Statements

LeMaitre Vascular shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although LeMaitre Vascular investors may analyze each financial statement separately, they are all interrelated. The changes in LeMaitre Vascular's assets and liabilities, for example, are also reflected in the revenues and expenses on on LeMaitre Vascular's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	127 M	133.4 M
Gross Profit Margin	0.66	0.76

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for LeMaitre Stock Analysis

When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC